NSE Closed
Markets
NIFTY 5024,774.31.60%NIFTY BANK58,247.951.72%NIFTY IT31,715.253.28%NIFTY FIN SERVICE26,984.451.47%INDIA VIX11.870.94%SENSEX78,639.030.70%LT4,0252.19%ICICIBANK1,4601.71%SBIN1,0451.71%ADANIENT3,0681.94%BAJFINANCE1,1531.03%RELIANCE1,3190.86%ITC2872.14%HDFCBANK7530.65%BHARTIARTL1,970.50.08%INFY1,1804.42%TCS2,473.74.57%NIFTY 5024,774.31.60%NIFTY BANK58,247.951.72%NIFTY IT31,715.253.28%NIFTY FIN SERVICE26,984.451.47%INDIA VIX11.870.94%SENSEX78,639.030.70%LT4,0252.19%ICICIBANK1,4601.71%SBIN1,0451.71%ADANIENT3,0681.94%BAJFINANCE1,1531.03%RELIANCE1,3190.86%ITC2872.14%HDFCBANK7530.65%BHARTIARTL1,970.50.08%INFY1,1804.42%TCS2,473.74.57%
HomeSymbolAUROPHARMA

Aurobindo Pharma Ltd.

NSE · AUROPHARMA · aurobindo.com
₹1,591
Last close · NSE/BSE
Set alert
Fundamentals
Mkt Cap
₹90,297.23 Cr
52W High
₹1,636.8
52W Low
₹1,016.1
P/E
98.03
EPS
₹15.86
Book Value
₹652.39
ROE
0.09%
ROCE
14.16%
ROA
0.06%
Profit margin
0.10%
Debt/Equity
0.21
P/B
2.38
Div Yield
0.00%
Rev. growth
9.39%
Sector
Pharmaceuticals
Ratios
Debtor days
66.1
Inventory days
121.3
Payable days
48.2
Cash conversion
139.2
Working cap. days
187.4
Interest coverage
12.1×
Dividend payout
Technicals · Members only

Unlock the technical read on $AUROPHARMA — RSI, MACD, moving averages and intraday pivot levels — free when you sign in.

  • RSI, MACD & trend strength (ADX)
  • Price vs 20/50/100/200-day averages
  • Support & resistance pivot levels
Sign in to unlock — freeCreate an account
Premium market data is free for bulls.plus members — just sign up and verify your email. For information only — not investment advice.
Shareholding · 2026-06
Promoter 51.88%FII 16.38%DII 25.10%Public 6.64%Pledge 13.75%Shareholders 2,39,073
Shareholding pattern
Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24
Promoter51.88%51.82%51.82%51.82%51.82%51.82%51.82%51.82%51.80%51.83%
— of which pledged13.75%23.65%17.50%17.50%17.08%16.92%17.83%20.39%20.88%20.86%
FII16.38%15.24%13.94%14.21%14.37%15.33%16.29%16.59%16.73%18.02%
DII25.10%25.87%27.68%27.60%26.93%26.23%25.20%25.13%24.77%23.28%
Public6.64%7.08%6.55%6.38%6.88%6.62%6.69%6.46%6.70%6.87%
Others1.28%1.34%1.19%1.13%1.21%1.15%1.17%1.14%1.23%1.36%
No. of shareholders2,39,0732,41,2982,36,8592,47,6622,72,2082,69,3232,57,9622,48,4882,38,6222,44,575
Quarterly SEBI shareholding filings (CMOTS). Latest 10 of 41 quarters shown.
Financials
₹ CrFY26FY25FY25FY25FY25FY25FY24
Revenue₹2,786.55₹2,747.28₹2,789.72₹2,848.17₹2,731.99₹32,345.58₹2,916.63
EBIT₹923.58₹847.71₹812.73₹810.09₹616.61₹5,555.22₹699.13
PBT₹5,066.29
Net Profit₹692.23₹582.07₹581.37₹559.13₹408.17₹3,485.88₹472.05
EPS (₹)₹59.81
Figures in ₹ crore · CMOTS fundamentals via api.ipo.plus
Company details
Kambam Nityananda ReddyVice Chairman & Managing Director
M Madan Mohan ReddyWhole-time Director
P V Ramprasad ReddyNon Executive Director
Girish Paman VanvariIndependent Director
P Sarath Chandra ReddyNon Executive Director
Santanu MukherjeeIndependent Director
M R KumarChairman & Independent Director
Satakarni MakkapatiNon Executive Director
B Adi ReddyCompany Sec. & Compli. Officer
Punita Kumar SinhaAdditional Director
Corporate actions
forthcoming Board MeetingsEx 2026-08-05
buyback ₹1475 maxEx 2026-04-29
dividend ₹4 (400%)Ex 2025-08-08
forthcoming Book Closure
Community sentiment · No signal
How do you feel about $AUROPHARMA? · 0 bull · 0 bear
Message volume
0
Quiet · 0 in 24h
Participation
· 0 accounts
Sentiment trend (30d)
Not enough history yet — building the sentiment trend.

$AUROPHARMA · Community

0 posts
No posts in $AUROPHARMA yet. Start the conversation.